A phase I study of recombinant human interferon alpha-2b combined with 5-fluorouracil and cisplatin in patients with advanced cancer

[1]  W. Panje,et al.  Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Markoe.  Manual of Oncologic Therapeutics, 1989/1990 , 1990 .

[3]  H. Hochster,et al.  Phase I study of the combination of alpha-2 interferon and cisplatinum. , 1989, Journal of biological response modifiers.

[4]  D. Lebrun,et al.  Sequential trial of initial chemotherapy for advanced cancer of the head and neck: DDP versus DDP + 5‐fluorouracil , 1988, Cancer.

[5]  H. Crissman,et al.  Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites. , 1988, Cancer research.

[6]  G. Bertelli,et al.  Cisplatin and 5-fluorouracil in refractory breast cancer patients: A phase II study , 1988, Breast Cancer Research and Treatment.

[7]  H. Blomgren,et al.  Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (Trial 1) and in combination with 5-fluorouracil (Trial 2) in advanced colorectal cancer , 1987, International Journal of Colorectal Disease.

[8]  F. Demard,et al.  Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. , 1986, British Journal of Cancer.

[9]  L. Kvols,et al.  Clinical Trial of Cisplatin and Intensive Course 5‐Fluorouracil for the Treatment of Advanced Colorectal Cancer , 1986, American journal of clinical oncology.

[10]  P. Weiden,et al.  Cisplatin bolus and 5-FU infusion chemotherapy for non-small cell lung cancer. , 1985, Cancer treatment reports.

[11]  T. Morgan,et al.  Combined recombinant human interferon alpha2 and cytotoxic agents studied in a clonogenic assay , 1985, International journal of cancer.

[12]  J. Jacobs,et al.  Cisplatin and 5‐fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck , 1984, Cancer.

[13]  H. Tanaka,et al.  In vitro studies on potentiation of cytotoxic effects of anticancer drugs by interferon on a human neoplastic cell line (HeLa). , 1983, Cancer letters.

[14]  M. Namba,et al.  Combined effects of 5-fluorouracil and interferon on proliferation of human neoplastic cells in culture. , 1982, Gan.

[15]  J. Jacobs,et al.  Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. , 1982, Cancer treatment reports.

[16]  J. Lindenmann,et al.  Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[17]  D. Alberts,et al.  Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay , 2004, Cancer Chemotherapy and Pharmacology.

[18]  R. Wittes.  Manual of oncologic therapeutics , 1991 .

[19]  M. Namba,et al.  Interferon potentiates cytotoxic effects of 5-fluorouracil on cell proliferation of established human cell lines originating from neoplastic tissues. , 1983, Cancer letters.